Given its upregulation in t-NEPC and potential involvement in aggressive tumor phenotypes, we considered three possible outcomes of FGF12 expression: (1) induction of NE differentiation; (2) promotion of cancer cell proliferation; (3) reduced sensitivity to chemotherapeutic reagent treatments. The gene discussed is FGF12; the disease is cancer.